2Korba BE. In vitro evaluation of combination therapies against hepatitis B virus replication. Antiviral Res, 1996, 29: 49-64.
3Schalm SW, Heathcote J, Cianclara J, et al. Lamivudlne and alpha interferon combination treatment of patients with chronichepatitis B infection: a randomised trial. Gut, 2000, 46: 562-568.
4Schiff E, Karayalcin S, Grimm I, et al. A placebo-controlled study of lamivudine and interferon alpha-2b in patients with chronic hepatitis B who previously failed interferon therapy.Hepatology, 1998, 28:388a.
5Mutimer D, Naoumov N, Honkoop P, et al. Combination alphainterferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection: results of a pilot study. J Hepatol,1998,28:923-929.
6Marinos G, Naoumov NV, Williams R. Impact of complete inhibition of viral replication on the cellular immune response inchronic hepatitis B virus infection. Hepatology, 1996, 24:991-995.
7Leung NWY, Lai CL, Chang TT, et al. Three year lamivudene therapy in chronic HB.J Hepatol, 1999,30 Suppl, 1:59.
8Cotonat T, Quiroga JA, Lopez-Alcorocho JM, et al. Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody positive patients.Hepatology, 2000, 31:502-506.
9PERRILLO R, SCHIFF E, YOSHIDA E, et al. Adefovir dipivolxil for the treatment of lamivudine-resistant hepatitis B mutants[J]. Hepatology, 2000, 32 (1): 129-134.
10LAI CL, CHIEN RN, LEUNG NWY, et al. A one year trail of lamivudine for chronic hepatitis B[J]. N Engl J Med, 1998, 339(2) :61-68.
